| Typicality: | 0.662 |
| Saliency: | 0.800 |
| for 24 weeks | 18 | temporal |
| for the first three months | 15 | temporal |
| for the same period | 10 | temporal |
| group → receive → placebo | 463 |
| group → be given → placebo | 207 |
| group → receive → the placebo | 62 |
| group → get → placebo | 38 |
| group → be given → the placebo | 13 |
| group → be on → placebo | 6 |
| group → get → the placebo | 5 |
| negative | neutral | positive |
| 0.197 | 0.722 | 0.081 |
| Raw frequency | 794 |
| Normalized frequency | 0.800 |
| Modifier score | 0.717 |
| Perplexity | 128.464 |